Viewing nowClojecs Tablet (Clopidogrel Sulfate)
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Samsung Pharm. Co., Ltd.

MFDS item code 201308825 · Approved 2013.08.14 · Insurance code 642306540
Improvement of acute coronary syndrome and atherosclerosis symptoms; reduction of thrombotic risk in atrial fibrillation
This medication is used to improve symptoms due to atherosclerosis in adult patients with ischemic stroke, myocardial infarction, or peripheral arterial disease. It also helps reduce cardiovascular risk related to atherosclerosis in patients with acute coronary syndrome, specifically those with unstable angina or non-Q-wave myocardial infarction who have undergone drug therapy, coronary intervention, or coronary artery bypass surgery. In cases where patients with atrial fibrillation have one or more vascular risk factors and a low bleeding risk, and where vitamin K antagonists are not appropriate, it is also used to reduce the risk of stroke and thromboembolism. This drug is effective in improving vascular health and reducing the risk of cardiovascular complications.
○ Adults 1. In patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. In patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start treatment with a loading dose of 300 mg of this medicine once daily on the first day of administration, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be administered concomitantly with this medicine once daily. 3. In patients with atrial fibrillation, administer 75 mg of this medicine orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this medicine once daily. ○ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment: Treatment experience in patients with moderate liver disease with a bleeding diathesis is limited. This medicine may be administered with or without food.
This medication is an agent that inhibits platelet aggregation in the blood, preventing thrombus formation. Patients with genetically reduced function of a specific enzyme (CYP2C19) may experience decreased effectiveness of this drug; in such cases, treatment options should be reconsidered or alternative medications should be considered. Moreover, co-administration with drugs that activate certain enzymes may lead to increased concentrations of the active ingredient of this drug, thereby increasing the risk of bleeding; hence, co-administration should be avoided. Patients who are allergic to this medication or its ingredients, those with bleeding disorders, severe liver impairment, lactating women, and those with genetic issues like lactose intolerance should not take this medication. Patients at high risk of bleeding, those with liver or kidney problems, recent stroke, hypertensive patients, the elderly, and underweight individuals should use this medication with caution and seek immediate medical advice if bleeding symptoms occur. This medication prolongs bleeding time; therefore, patients scheduled for surgery should discontinue it 5-7 days prior to the procedure, and caution is advised when used with other drugs that increase bleeding risk. During treatment, if bleeding symptoms or adverse reactions occur, patients should notify their doctor promptly and undergo appropriate tests such as blood tests. This medication can cause various side effects such as gastrointestinal disturbances, rash, headache, dizziness, diarrhea, nausea, high cholesterol, joint pain, back pain, bruising, epistaxis, depression, upper respiratory infections, rhinitis, bronchitis, cough, pruritus, urinary tract infections, chest pain, weight loss, weight gain, flushing, weakness, stiffness, facial swelling, syncope, constipation, vomiting, ulcers, and loss of appetite, most of which are mild or similar to the effects of aspirin. While the risk to the fetus during pregnancy is not known, caution should be exercised due to the increased risk of bleeding during delivery. Lactating women should decide on use after consulting their physician. Safety and efficacy in children have not been established; therefore, it is advisable not to administer this medication to children. Overdose may increase the risk of bleeding; there is no specific antidote, but platelet transfusions can reverse the effects. This medication should be stored out of reach of children and should not be transferred to other containers. Patients taking this medication are not known to be significantly affected when driving or operating machinery, but individual variations may occur; hence, caution is advised.
Hemorrhage, gastrointestinal bleeding, purpura, contusion, hematoma, epistaxis, hematoma, hematuria, intraocular hemorrhage, intracranial hemorrhage, thrombocytopenia, neutropenia, aplastic anemia, abdominal pain, dyspepsia, diarrhea, nausea, rash, pruritus, chest pain, accidental injury, influenza-like illness, pain, fatigue, edema, hypertension, headache, dizziness, depression, upper respiratory tract infection, dyspnea, rhinitis, bronchitis, cough, urinary tract infection, reduced motor function, tremor, voice disorder, abnormal gait, hyperkinesia, ataxia, sensory disturbance, constipation, vomiting, ulcer, abdominal pain, anorexia, hiccups, thirst, dysphagia, tongue disease, insomnia, depression, amnesia, anxiety, confusion, delusion, abnormal behavior, rigidity, facial edema, syncope, purpura, hematochezia, thrombocytopenia, anemia, pneumonia, sinusitis, visual disturbance, field disturbance, dry eyes, transient blindness, congestion, tinnitus, dysgeusia, urination disorders, polyuria, non-protein nitrogen increase, uremia, elevated blood urea nitrogen, hypoglycemia, hyperuricemia, increased liver enzymes, elevated ALT, liver function abnormalities, leg edema, arrhythmia, bradycardia, palpitations, contact dermatitis, gynecomastia, elevated prostate-specific antigen, allergic symptoms, ischemic necrosis, gastritis, hemorrhagic gastroenteritis, duodenal ulcer, gastric ulcer, perforated gastric ulcer, upper gastrointestinal ulcer bleeding, distension, hyperbilirubinemia, infectious hepatitis, fatty liver, hemorrhagic arthropathy, hematuria, hemoptysis, retroperitoneal hemorrhage, surgical wound bleeding, pulmonary hemorrhage, thrombocytopenia, hypochromic anemia, agranulocytosis, granulocytopenia, leukemia, leukopenia, eosinophilia, menorrhagia, hematothorax, herpes zoster, erythematous rash, maculopapular rash, urticaria, renal dysfunction, acute kidney failure, cholecystitis, hematemesis, spinal hematoma, confusion, hallucinations, taste disorder, loss of taste, vasculitis, hypotension, bronchospasm, interstitial pneumonia, eosinophilic pneumonia, colitis, pancreatitis, stomatitis, hepatitis, acute liver failure, maculopapular rash, urticaria, itching, angioedema, vesicular dermatitis, drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms, eczema, lichen planus, arthralgia, arthritis, myalgia, glomerulopathy, gynecomastia, fever
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. The recommended storage temperature is between 1 degree and 30 degrees Celsius at room temperature. This helps to safely maintain the efficacy of the drug.
Pink round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowClopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Samsung Pharm. Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Geonil Pharmaceutical Co., Ltd.
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
(Co., Ltd.) Korea Pharma

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.